Vasopressin Antagonists and Dilutional Hyponatremia
The paradox of dilutional hyponatremia, as described by Ovid two millennia ago, continues to apply to patients with advanced cirrhosis today: they have unremitting thirst despite vastly increased total body water. Hyponatremia of less than 130 mmol/L occurs in 30% of cirrhotic patients (1), and...
Saved in:
Main Authors: | D Mohamed Babatin, Samuel S Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2004/591609 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyponatremia due to preserved non-osmotic arginine vasopressin secretion in adipsic diabetes insipidus: a case report with review of literature
by: Yasufumi Seki, et al.
Published: (2024-11-01) -
Low-Dose Tolvaptan for the Treatment of Dilutional Hyponatremia in Cirrhosis: A Case Report and Literature Review
by: Guo Shen, et al.
Published: (2014-01-01) -
Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry
by: Samuel H. Sigal, et al.
Published: (2018-01-01) -
Corrigendum to “Management Challenges in a Child with Chronic Hyponatremia: Use of V2 Receptor Antagonist”
by: Sowmya Krishnan, et al.
Published: (2017-01-01) -
Noncanonical effects of vasopressin in angiogenesis
by: I. I. Khegay
Published: (2019-08-01)